NIH study: Moderna, Pfizer shots are most effective Covid boosters
@rt.com4 years ago
UK Health Sec withheld promising vaccine data from PM, potentially influencing decision to extend Covid restrictions – media
@WSJ4 years ago
Johnson & Johnson is planning to start a second large clinical trial soon for its experimental Covid-19 vaccine, this time testing with two doses, rather than the single dose being tested in another large study that is ongoing on.wsj.com
@WSJ4 years ago
Johnson & Johnson is pausing its clinical trials of a Covid-19 vaccine after a study volunteer had an unexplained illness #WSJWhatsNowt.co
@axios.com4 years ago
Johnson & Johnson pauses COVID-19 vaccine study due to "unexplained illness" in patient
@abcnews.go.com4 years ago
Late-stage study of first single-shot vaccine begins in US
@WSJ3 years ago
A booster shot of Johnson & Johnson’s Covid-19 vaccine showed signs of significantly bolstering the immune defenses of study subjects, said FDA regulators, who cautioned that their data was limited on.wsj.com
@forbes.com4 years ago
Some Covid-19 Vaccine Reactions Are Actually The Result Of Anxiety, Study Finds
@WSJ4 years ago
Johnson & Johnson paused its clinical trials of a Covid-19 vaccine after a study volunteer had an unexplained illness. See a guide to the front-runners in the race to produce a safe and effective vaccine. on.wsj.com
@WSJ4 years ago
Johnson & Johnson said it has paused further dosing in all clinical trials of its experimental Covid-19 vaccine because a study volunteer had an unexplained illness on.wsj.com
@WSJ4 years ago
A Covid-19 vaccine under development by Johnson & Johnson tested well in a preliminary study, producing immune responses and appearing safe, according to a study posted online Friday on.wsj.com
@snopes.com4 years ago
Late-Stage Study of First Single-Shot Vaccine Begins in US
@nytimes.com3 years ago
Johnson & Johnson to Seek F.D.A. Authorization for Booster Shot
@forbes.com4 years ago
Johnson & Johnson Covid-19 Vaccine Updates: South African Roll-out, FDA Reviews
@WSJ4 years ago
Johnson & Johnson paused its clinical trials of a Covid-19 vaccine after a study volunteer had an unexplained illness. See a guide to the front-runners in the race to produce a safe and effective vaccine. on.wsj.com
@theguardian.com4 years ago
Johnson & Johnson pauses Covid vaccine trial over participant's 'unexplained illness'
@WSJ4 years ago
A trial testing whether a single dose of Johnson & Johnson’s vaccine can safely protect people from Covid-19 follows an earlier study that showed promising results. Four experimental coronavirus shots have now entered Phase 3 testing in the U.S. on.wsj.com
@forbes.com3 years ago
J&J Booster Shot Offers 94% Protection Against Symptomatic Covid, Company Says
@forbes.com4 years ago
South Africa Abandons Oxford-AstraZeneca Covid-19 Vaccine In Favor Of Unapproved Johnson & Johnson Shot
@WSJ4 years ago
Johnson & Johnson’s Covid-19 vaccine trial could resume shortly, company executives said—but first outside researchers have to figure out what sickened the volunteer and led to a halt in the study on.wsj.com
@WSJ4 years ago
Johnson & Johnson paused all trials of its Covid-19 vaccine, including a final-stage U.S. study, after a volunteer had an unexplained illness on.wsj.com
@abcnews.go.com4 years ago
Late-stage study of first single-shot vaccine begins in US